Study of Biomarkers in Tissue Samples From Patients With Breast Cancer
NCT01004796 · Status: UNKNOWN · Type: OBSERVATIONAL
Last updated 2016-02-29
Summary
RATIONALE: Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer.
PURPOSE: This research study is looking at tissue samples from patients with breast cancer.
Conditions
Interventions
- GENETIC
-
cytogenetic analysis
- GENETIC
-
microarray analysis
- GENETIC
-
mutation analysis
- OTHER
-
immunohistochemistry staining method
- OTHER
-
immunologic technique
- OTHER
-
mass spectrometry
Sponsors & Collaborators
-
National Cancer Institute (NCI)
collaborator NIH -
University of Wisconsin, Madison
lead OTHER
Principal Investigators
-
Janet E. Mertz, PhD · University of Wisconsin, Madison
Eligibility
- Max Age
- 120 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
More Related Trials
-
Molecular Analysis of Breast Cancer
NCT00569049 ·Status: COMPLETED
-
Correlation of Molecular Markers With Response to Therapy and Breast Cancer Behavior
NCT01000883 ·Status: RECRUITING
-
Studying Biomarkers in Nipple Fluid, Urine, and Blood Samples From Women With Newly Diagnosed Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer and in Women at Risk of Developing Breast Cancer
NCT00897208 ·Status: COMPLETED
-
Susceptibility to Breast Cancer
NCT00004565 ·Status: COMPLETED
-
Studying Tumor Tissue Samples From Patients With Early-Stage Breast Cancer
NCT00899639 ·Status: WITHDRAWN
-
MRI Parenchymal Enhancement: A New Marker of Breast Cancer Risk
NCT01649661 ·Status: COMPLETED
-
Identifying Genes That Predict Recurrence in Women With Breast Cancer Treated With Chemotherapy
NCT00897299 ·Status: COMPLETED
-
Markers for Breast Cancer
NCT00339248 ·Status: COMPLETED
-
Studying Blood Samples in Women With Breast Cancer or a History of Breast Cancer
NCT00898703 ·Status: COMPLETED
-
Nutrition-Related Biomarkers in Predicting Breast Cancer Risk in Women
NCT00900367 ·Status: ACTIVE_NOT_RECRUITING
-
Biomarkers in Tissue Samples From Patients With Breast Cancer Treated With Bevacizumab
NCT01156168 ·Status: COMPLETED
-
Biomarkers in Predicting Response to Tamoxifen and Letrozole in Postmenopausal Women With Primary Breast Cancer Treated on Clinical Trial CAN-NCIC-MA17
NCT00897065 ·Status: UNKNOWN
-
Genetic and Protein Profiling in Normal and Cancerous Breast Tissue
NCT00083733 ·Status: COMPLETED
-
A Study of ZN-c5 in Participants With Breast Cancer
NCT04176757 ·Status: COMPLETED ·Phase: PHASE1
-
High Risk Breast Clinic: Protocol for Women at Increased Risk for Developing Breast Cancer
NCT00291096 ·Status: RECRUITING
-
Studying Normal Breast Tissue and Cancer Risk
NCT00341692 ·Status: COMPLETED
-
Nipple Secretion Samples in Detecting Breast Cancer in Patients and Healthy Participants Undergoing Breast Cancer Screening, Breast Diagnostic Studies, or Treatment for Benign Breast Disease
NCT00813878 ·Status: TERMINATED
-
Prognostic Value of Stem Cell Related Markers
NCT01265225 ·Status: WITHDRAWN
-
S8814A Biomarkers in Predicting Outcome in Postmenopausal Women With Hormone Receptor-Positive, Node-Positive Breast Cancer Treated With Tamoxifen With or Without Cyclophosphamide, Doxorubicin, and Fluorouracil
NCT00897091 ·Status: COMPLETED
-
Assessment of Candidate Protein Expression in Breast Cancer Specimens
NCT00918892 ·Status: COMPLETED
-
Tumor Suppressor Status as a Predictor of Chemotherapy Response in Triple Negative Breast Cancer
NCT01514565 ·Status: UNKNOWN
-
Studying Breast Cancer Risk in Women Who Are BRCA1/BRCA2 Mutation Carriers
NCT00897455 ·Status: UNKNOWN
-
Breast Cancer Survivorship Biorepository
NCT05786664 ·Status: RECRUITING
-
Feasibility Study of Evaluating Breast Cancer Patients With Ductal Lavage
NCT00156260 ·Status: TERMINATED
-
Studying Tissue Samples From Women With Breast Cancer Who Were Treated on Clinical Trial NCCTG-N9831
NCT00898898 ·Status: COMPLETED